Provided by Tiger Trade Technology Pte. Ltd.

Nexalin Technology, Inc.

0.3348
-0.0253-7.03%
Post-market: 0.33480.00000.00%19:57 EDT
Volume:99.58K
Turnover:35.10K
Market Cap:7.21M
PE:-0.72
High:0.3737
Open:0.3600
Low:0.3302
Close:0.3601
52wk High:2.00
52wk Low:0.3050
Shares:21.54M
Float Shares:17.86M
Volume Ratio:0.67
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4623
EPS(LYR):-0.5016
ROE:-319.69%
ROA:-161.10%
PB:2.50
PE(LYR):-0.67

Loading ...

Company Profile

Company Name:
Nexalin Technology, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
8
Office Location:
1776 Yorktown,Suite 550,Houston,Texas,United States
Zip Code:
77056
Fax:
- -
Introduction:
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.

Directors

Name
Position
Mark White
Chief Executive Officer and Director and President
David Owens
Chief Medical Officer and Director
Alan Kazden
Director
Ben Hu
Director
Leslie Bernhard
Director

Shareholders

Name
Position
Mark White
Chief Executive Officer and Director and President
Carolyn Shelton
Senior Vice President of Quality, Clinical and Regulatory
Justin Van Fleet
Chief Financial Officer
David Owens
Chief Medical Officer and Director